NL-OMON33520已完成不适用
Bevacizumab and vasoconstriction - Bevacizumab and vasoconstriction
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Age 18-50years old
- •3. Results of serum glucose, lipids and creatinine should be within the laboratory's reference ranges.
- •4. Subject is able and willing to sign the Informed Consent Form prior to screening evaluations.
排除标准
- •1. Documented history of sensitivity/idiosyncrasy to medicinal products or excipients.
- •2. History of or current abuse of drugs, alcohol or solvents.
- •3. History of malignant disease.
- •4. First degree relatives with a history of cancer before the age of 50
- •5. Current use of medication.
- •6. Clinical evidence of cardiac or pulmonary disease
- •7. Hypertension ( systole >140mmHG, diastole >90mmHg)
- •8. Diabetes mellitus
- •9. Smoking
- •10. Any clinically relevant abnormality on ECG.
- •11. Inability to understand the nature and extent of the trial and the procedures required.
研究者
相似试验
已完成
不适用
Bevacizumab and endothelium dependent vasodilatiohigh blood pressure10057166HypertensionNL-OMON32503niversitair Medisch Centrum Sint Radboud24
进行中（未招募）
不适用
Phase II Study of the Combination of Bevacizumab (rhuMAb VEGF) and Oxaliplatin plus Capecitabine (XELOX) in Patients with Advanced Colorectal CancerEUCTR2005-001012-41-ITROCHE
进行中（未招募）
不适用
Phase II study of the combination of Bevacizumab (rhuMab VEGF) plus Capecitabine with pre-operative standard radiotherapy in patients with locally advanced rectal cancer.Patients with locally advanced, non metastatic, resectable primary rectal cancer stage cT3 or cT4 who are subject to combined chemotherapy of the pelvic region in the pre-operative setting.MedDRA version: 14.1Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2005-000802-30-ITROCHE
招募中
不适用
A clinical study of Bevacizumab therapy in combination with chemotherapeutic drugs for children with recurrent gliomaJPRN-UMIN000005528Osaka University Graduate School of Medicine12
招募中
2 期
A PhaseII Study of Bevacizumab in Combination with S-1 in Patients with Non-Squamous Non-Small-Cell Lung Cancer reviously treated with platinum based chemotherapyon-Squamous Non-Small-Cell Lung CancerJPRN-UMIN000005486Hiroshima citizens hospital Department of Medical Oncology34